REGENXBIO, Inc. (RGNX)
6.125
+0.04
(+0.74%)
USD |
NASDAQ |
Jun 08, 16:00
6.125
0.00 (0.00%)
After-Hours: 19:35
REGENXBIO Total Liabilities (Quarterly) : 320.81M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Ocugen, Inc. | 51.10M |
| Capricor Therapeutics, Inc. | 47.58M |
| Krystal Biotech, Inc. | 120.24M |
| Biogen, Inc. | 10.83B |
| AbbVie, Inc. | 143.08B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 341.89M |
| Shareholders Equity (Quarterly) | 21.08M |
| Debt to Equity Ratio | 11.78 |
| Current Ratio | 2.623 |
| Net Debt Paydown Yield | -4.93% |